Senators Slam AveXis, Call For FDA Retribution, Stricter Regulation

By David Roza
August 9, 2019 at 3:00 PM
A group of five senators, including 2020 presidential hopefuls Elizabeth Warren (D-MA) and Bernie Sanders (I-VT), pilloried drug-maker AveXis on Friday (Aug. 9) for not telling FDA it had manipulated testing data for its new gene therapy drug, Zolgensma, until after the drug’s approval. The lawmakers argued that the secrecy smacked of greed and privilege, considering the drug had been developed in part through taxpayer-funded research and accelerated approval pathways. Though FDA has said the manipulation did not affect Zolgensma’s...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.